AtriCure
ATRC
155 hedge funds and large institutions have $1.21B invested in AtriCure in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 45 increasing their positions, 59 reducing their positions, and 18 closing their positions.
474% more call options, than puts
Call options by funds: $22.2M | Put options by funds: $3.86M
89% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 18
10% more funds holding
Funds holding: 141 → 155 (+14)
7% more capital invested
Capital invested by funds: $1.13B → $1.21B (+$76M)
1.75% more ownership
Funds ownership: 88.24% → 89.99% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
24% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 59
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$45.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$42.9M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$32.4M |
| 4 |
O
OrbiMed
New York
|
+$27.3M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$15.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$85.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$16.4M |
| 3 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$14.3M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$13M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$9.96M |
ATRC Hedge Fund Activity: Q1 2020 in Review
155 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q1 2020, worth a combined $1.21B — up 6.7% from $1.13B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new ATRC positions and 18 closed out — a net gain of 16 holders — while 45 added to existing stakes and 59 trimmed.
The largest buyer was Fred Alger Management, opening a new position worth an estimated $45.4M. The largest seller was Fidelity Investments, cutting an estimated $85.9M.
- 155 institutional investors held AtriCure (ATRC) as of Q1 2020, up from 141 in Q4 2019.
- Funds reported $1.21B of AtriCure stock for Q1 2020, up 6.7% quarter-over-quarter.
- 34 funds opened new AtriCure positions in Q1 2020 and 18 closed out, a net change of +16 holders.
- The largest AtriCure buyer in Q1 2020 was Fred Alger Management, an estimated $45.4M added.
- The largest AtriCure seller in Q1 2020 was Fidelity Investments, an estimated $85.9M sold.
Based on aggregated 13F filings for Q1 2020.